Drug Treatments for Inflammatory Bowel Diseases
We are pleased to inform you that the Special Issue reprint “Drug Treatments for Inflammatory Bowel Diseases” has been published online and is freely accessible on the MDPI Books platform. We hope that the reprint meets the reader's expectations in the field and further promotes investigations into...
Đã lưu trong:
| Định dạng: | Online |
|---|---|
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Những chủ đề: | |
| Truy cập trực tuyến: | ONIX_20240514_9783036599762_62 |
| Các nhãn: |
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1869521032729067520 |
|---|---|
| collection | Directory of Open Access Books |
| description | We are pleased to inform you that the Special Issue reprint “Drug Treatments for Inflammatory Bowel Diseases” has been published online and is freely accessible on the MDPI Books platform. We hope that the reprint meets the reader's expectations in the field and further promotes investigations into the treatment of IBD by the scientific community. |
| format | Online |
| id | doab-20.500.12854ir-137460 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1374602024-05-14T13:09:25Z Drug Treatments for Inflammatory Bowel Diseases Luiz-Ferreira, Anderson Stolfi, Carmine Ren-Shen-Bai-Du Powder (RSBDP) inflammatory bowel disease network pharmacology molecular docking underlying mechanism cytokines lymphocyte homing Crohn’s Disease MK2 MAPKAPK2 checkpoint molecules Lag3 PD-L1 matrix metalloproteinases (MMPs) diabetes mellitus pharmacoepidemiology pioglitazone Taiwan vedolizumab treatment outcome 5-ASA anti-TNF gene expression Crohn’s disease ulcerative colitis miR-497a-5p TGF-β macrophage rosiglitazone type 2 diabetes mellitus ketone esters (R,R)-BD-AcAc2 NLRP3 inflammasome pyroptosis autophagy gut dysbiosis IBD oxidative stress ROS corticosteroid immunomodulator biological therapy JAK s1P n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology We are pleased to inform you that the Special Issue reprint “Drug Treatments for Inflammatory Bowel Diseases” has been published online and is freely accessible on the MDPI Books platform. We hope that the reprint meets the reader's expectations in the field and further promotes investigations into the treatment of IBD by the scientific community. 2024-05-14T13:09:22Z 2024-05-14T13:09:22Z 2024 book ONIX_20240514_9783036599762_62 9783036599762 9783036599755 https://directory.doabooks.org/handle/20.500.12854/137460 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/8615 https://mdpi.com/books/pdfview/book/8615 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-9975-5 10.3390/books978-3-0365-9975-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036599762 9783036599755 202 open access |
| spellingShingle | Ren-Shen-Bai-Du Powder (RSBDP) inflammatory bowel disease network pharmacology molecular docking underlying mechanism cytokines lymphocyte homing Crohn’s Disease MK2 MAPKAPK2 checkpoint molecules Lag3 PD-L1 matrix metalloproteinases (MMPs) diabetes mellitus pharmacoepidemiology pioglitazone Taiwan vedolizumab treatment outcome 5-ASA anti-TNF gene expression Crohn’s disease ulcerative colitis miR-497a-5p TGF-β macrophage rosiglitazone type 2 diabetes mellitus ketone esters (R,R)-BD-AcAc2 NLRP3 inflammasome pyroptosis autophagy gut dysbiosis IBD oxidative stress ROS corticosteroid immunomodulator biological therapy JAK s1P n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology Drug Treatments for Inflammatory Bowel Diseases |
| title | Drug Treatments for Inflammatory Bowel Diseases |
| title_full | Drug Treatments for Inflammatory Bowel Diseases |
| title_fullStr | Drug Treatments for Inflammatory Bowel Diseases |
| title_full_unstemmed | Drug Treatments for Inflammatory Bowel Diseases |
| title_short | Drug Treatments for Inflammatory Bowel Diseases |
| title_sort | drug treatments for inflammatory bowel diseases |
| topic | Ren-Shen-Bai-Du Powder (RSBDP) inflammatory bowel disease network pharmacology molecular docking underlying mechanism cytokines lymphocyte homing Crohn’s Disease MK2 MAPKAPK2 checkpoint molecules Lag3 PD-L1 matrix metalloproteinases (MMPs) diabetes mellitus pharmacoepidemiology pioglitazone Taiwan vedolizumab treatment outcome 5-ASA anti-TNF gene expression Crohn’s disease ulcerative colitis miR-497a-5p TGF-β macrophage rosiglitazone type 2 diabetes mellitus ketone esters (R,R)-BD-AcAc2 NLRP3 inflammasome pyroptosis autophagy gut dysbiosis IBD oxidative stress ROS corticosteroid immunomodulator biological therapy JAK s1P n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology |
| topic_facet | Ren-Shen-Bai-Du Powder (RSBDP) inflammatory bowel disease network pharmacology molecular docking underlying mechanism cytokines lymphocyte homing Crohn’s Disease MK2 MAPKAPK2 checkpoint molecules Lag3 PD-L1 matrix metalloproteinases (MMPs) diabetes mellitus pharmacoepidemiology pioglitazone Taiwan vedolizumab treatment outcome 5-ASA anti-TNF gene expression Crohn’s disease ulcerative colitis miR-497a-5p TGF-β macrophage rosiglitazone type 2 diabetes mellitus ketone esters (R,R)-BD-AcAc2 NLRP3 inflammasome pyroptosis autophagy gut dysbiosis IBD oxidative stress ROS corticosteroid immunomodulator biological therapy JAK s1P n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology |
| url | ONIX_20240514_9783036599762_62 |